ESR1 and neoplasm: In order to understand the heterogeneity of the intertumoral microenvironment, we collected scRNA-Seq data of tumor tissues from five TNBC patients diagnosed with ER/PR/HER2 negative status from the MD Anderson Cancer Center (GSE148673 [19]).